Sivasubramanian Kumar, Bharath R Raj, Vajravelu Leela Kakithakara, Kumar D Madan, Banerjee Aritra
Department of Microbiology, SRM Medical College Hospital and Research Center, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu 603203, Tamil Nadu, India.
Department of Transfusion Medicine & Blood Centre, SRM Medical College Hospital and Research Center, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu 603203, Tamil Nadu, India.
Viruses. 2025 Apr 30;17(5):661. doi: 10.3390/v17050661.
Dengue virus is the most prevalent arthropod-borne viral disease in humans. Severe dengue, defined by hemorrhagic fever and dengue shock syndrome, can develop quickly in people who have warning indications such as abdominal pain, mucosal bleeding, and a significant decrease in platelet count. Laboratory markers such as hematocrit, platelet count, liver enzymes, and coagulation tests are critical for early diagnosis and prognosis. This retrospective study was carried out from January 2023 to December 2024 at a super-specialty tertiary care hospital. There were 283 adult patients with dengue with warning signs, who were categorized into 102 with platelet transfusion and 181 with no platelet transfusion. Data on patient demographics, clinical history, laboratory values, and radiological findings were systematically obtained from hospital records at the time of admission. Laboratory parameters such as white blood cell (OR = 2.137), hemoglobin (OR = 2.15), aPTT (OR = 5.815), AST/ALT (OR = 2.431), platelet count (OR = 26.261) and NS1 (OR = 4.279) were found to be significantly associated ( < 0.01) with platelet transfusion. Similarly, an increased prothrombin time (OR = 2.432) contributed to prolonged hospital stays and the presence of ascites (OR = 5.059), gallbladder wall thickening (OR = 4.212), and pleural effusion (OR = 2.917), contributing to the severity of the dengue infection. These significant laboratory markers help with identifying patients with dengue who may develop severe dengue, requiring platelet transfusion, thereby prioritizing patient care and enabling the implementation of targeted interventions.
登革病毒是人类中最普遍的节肢动物传播病毒性疾病。由出血热和登革休克综合征定义的严重登革热,可在出现腹痛、黏膜出血和血小板计数显著下降等警示迹象的人群中迅速发展。血细胞比容、血小板计数、肝酶和凝血试验等实验室指标对于早期诊断和预后至关重要。这项回顾性研究于2023年1月至2024年12月在一家超专科三级护理医院进行。有283例有警示体征的成年登革热患者,其中102例接受了血小板输注,181例未接受血小板输注。在入院时从医院记录中系统获取了患者人口统计学、临床病史、实验室值和影像学检查结果等数据。发现白细胞(OR = 2.137)、血红蛋白(OR = 2.15)、活化部分凝血活酶时间(OR = 5.815)、谷草转氨酶/谷丙转氨酶(OR = 2.431)、血小板计数(OR = 26.261)和NS1(OR = 4.279)等实验室参数与血小板输注显著相关(<0.01)。同样,凝血酶原时间延长(OR = 2.432)导致住院时间延长,腹水(OR = 5.059)、胆囊壁增厚(OR = 4.212)和胸腔积液(OR = 2.917)的存在导致登革热感染的严重程度增加。这些重要的实验室指标有助于识别可能发展为严重登革热、需要输注血小板的登革热患者,从而优先安排患者护理并实施有针对性的干预措施。